Zobrazeno 1 - 10
of 96
pro vyhledávání: '"James R. Oleson"'
Publikováno v:
Cancers. 14(7)
Numerous randomized trials have revealed that hyperthermia (HT) + radiotherapy or chemotherapy improves local tumor control, progression free and overall survival vs. radiotherapy or chemotherapy alone. Despite these successes, however, some individu
Autor:
James R. Oleson
Publikováno v:
Hyperthermia in Cancer Treatment ISBN: 9780429266546
Hyperthermia in Cancer Treatment
Hyperthermia in Cancer Treatment
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8beb5a68c5c91d21cd01fd84dee32955
https://doi.org/10.1201/9780429266546-8
https://doi.org/10.1201/9780429266546-8
Autor:
Joseph K. Salama, Karthik Vishwanath, Nimmi Ramanujam, Alaattin Erkanli, James R. Oleson, Fangyao Hu, David M. Brizel, Walter T. Lee, Bercedis Peterson, Mark W. Dewhirst
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 96:462-469
Purpose To test whether oxygenation kinetics correlate with the likelihood for local tumor control after fractionated radiation therapy. Methods and Materials We used diffuse reflectance spectroscopy to noninvasively measure tumor vascular oxygenatio
Publikováno v:
Medical physics. 39(6Part6)
Purpose: To study prostate‐bed motion after prostatectomy using the surgical clips as a surrogate. Methods: On the treatment planningCT, surgical clips within the PTV are identified and contoured. They are also identified and contoured in each dail
Autor:
Oana Craciunescu, Zeljko Vujaskovic, Leonard R. Prosnitz, Kimberly L. Blackwell, James R. Oleson, Mark W. Dewhirst, Ellen L. Jones, Timothy M. Zagar
Publikováno v:
International Journal of Hyperthermia. 26:612-617
Hyperthermia has long been used in combination with radiation for the treatment of superficial malignancies, in part due to its radiosensitising capabilities. Patients who suffer superficial recurrences of breast cancer, be it in their chest wall fol
Autor:
James R. Oleson, Kimberly L. Blackwell, Zeljko Vujaskovic, Oana Craciunescu, Mark W. Dewhirst, Ellen L. Jones, Leonard R. Prosnitz, Timothy M. Zagar
Publikováno v:
International Journal of Hyperthermia. 26:618-624
Hyperthermia (HT) has a proven benefit for treating superficial malignancies, particularly chest wall recurrences of breast cancer. There has been less research utilising HT in patients with locally advanced breast cancer (LABC), but available data a
Autor:
Betsy D. Hughes, Austin K. Mattox, James R. Oleson, David A. Reardon, Roger E. McLendon, Cory Adamson
Publikováno v:
Cancer. 117:24-38
Primary extradural meningiomas (PEMs) represent about 2% of all meningiomas and are often encountered by non-neurosurgeons. These lesions typically present as enlarging, painless, benign masses that can be surgically cured. Imaging is critical for de
Autor:
James R. Oleson, Shiva K. Das, John W. Nelson, Gloria Broadwater, Ali K. Alkaissi, Junzo Chino, Edward F. Miles, Robert W. Clough, Mitchell S. Anscher
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 77:139-146
Purpose To assess the correlation of postimplant dosimetric quantifiers with biochemical control of prostate cancer after low–dose rate brachytherapy. Methods and Materials The biologically effective dose (BED), dose in Gray (Gy) to 90% of prostate
Autor:
Bridget F. Koontz, Sigrun Bynum, Gustavo S. Montana, Suzanne Catalano, James R. Oleson, K. Temple, Shiva K. Das, Jason I. Koontz
Publikováno v:
Medical Dosimetry. 34:256-260
Adjuvant radiotherapy for locally advanced prostate cancer improves biochemical and clinical disease-free survival. While comparisons in intact prostate cancer show a benefit for intensity modulated radiation therapy (IMRT) over 3D conformal planning
Autor:
Robert W. Clough, Mitchell S. Anscher, James R. Oleson, Ali K. Alkaissi, Edward F. Miles, John W. Nelson, Shiva K. Das
Publikováno v:
Brachytherapy. 7:206-211
To assess the correlation of postimplant dosimetric quantifiers with biochemical control of prostate cancer after low-dose-rate brachytherapy.Generalized equivalent uniform dose (EUD), dose in Gy to 90% of the prostate gland (D(90)), and percentage o